Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise.

Juri Park Sung Woo ParkKun Ho YoonSung Rae KimKyu Jeung AhnJae Hyuk LeeJi Oh MokChoon Hee ChungKyung Ah HanGwan Pyo KohJun Goo KangChang Beom LeeSeong Hwan KimNa Young KwonDoo Man Kim

Published in: Diabetes, obesity & metabolism (2017)

In this 24-week study, once-daily evogliptin monotherapy significantly improved glycaemic control and was well tolerated in patients with T2D.

Keyphrases

physical activity
combination therapy
type diabetes
open label
high intensity
weight loss
randomized controlled trial
resistance training
body composition